Sientra Stock News

The U.S. plastic surgery market is thought to be worth around $13 billion. With its new acquisition, Sientra (SIEN) will be hoping to improve its positioning in thi

Sientra Inc (SIEN) shares closed 4.2% lower than its previous 52 week low, giving the company a market cap of $201M. The stock is currently down 5.7% year-to-date, down 10.6% over the past 12 months, and down 59.8% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 20.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -598.4% The company's stock price performance over the past 12 months lags the peer average by -126.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

SANTA BARBARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art

Royal Bank of Canada trimmed its position in shares of Sientra, Inc. (NASDAQ:SIEN) by 19.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,170 shares of the medical instruments supplier’s stock after selling 6,284 shares during the quarter. Royal Bank […]

Wall Street analysts expect Sientra, Inc. (NASDAQ:SIEN) to report sales of $19.90 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Sientras earnings. Sientra reported sales of $22.64 million in the same quarter last year, which indicates a negative year-over-year growth rate of 12.1%. The firm is expected []

Metropolitan Life Insurance Co NY grew its stake in Sientra, Inc. (NASDAQ:SIEN) by 45,920.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,903 shares of the medical instruments suppliers stock after purchasing an additional 6,888 shares during the quarter. Metropolitan Life []

SANTA BARBARA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it has entered into exclusive agreements with Kai Aesthetics, Inc., and Paragon Meditech Company for the distribution of Sientras breast implants in Canada and China, respectively. 1

Global Breast Reconstruction Market Synopsis: According to the world class Breast Reconstruction Market report, the leading players are focusing more on offering products at rational prices to gain a competitive advantage over the other players in the Healthcare industry. The main

Charles Schwab Investment Management Inc. lifted its holdings in shares of Sientra, Inc. (NASDAQ:SIEN) by 8.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 142,936 shares of the medical instruments suppliers stock after buying an additional 11,364 shares during the quarter. Charles []

Wall Street analysts forecast that Sientra, Inc. (NASDAQ:SIEN) will announce sales of $19.90 million for the current quarter, according to Zacks. Two analysts have provided estimates for Sientras earnings. Sientra posted sales of $22.64 million in the same quarter last year, which would indicate a negative year over year growth rate of 12.1%. The firm []

State Street Corp grew its holdings in Sientra, Inc. (NASDAQ:SIEN) by 13.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 874,084 shares of the medical instruments suppliers stock after buying an additional 106,102 shares during the quarter. State Street Corps holdings in Sientra were worth $6,958,000 as of its most recent SEC filing. Several []

Amalgamated Bank acquired a new position in shares of Sientra, Inc. (NASDAQ:SIEN) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 10,502 shares of the medical instruments suppliers stock, valued at approximately $84,000. Other hedge funds and other institutional investors also recently modified their holdings of []

Key Companies in Breast Implants Market are Sientra, Inc. (California, U.S.) , GC Aesthetics (Dublin, Ireland) , POLYTECH Health & Aesthetics GmbH (Dieburg, Germany) , AbbVie Inc. (Illinois, U.S.) , Mentor Worldwide LLC (California, U.S.) , CEREPLAS (Cambrai, France) , Establishment Labs S.A. (Alajuela, Costa Rica) , LABORATOIRES ARION (Sophia Antipolis, France) , Other Players Key Companies in Breast Implants Market are Sientra, Inc. (California, U.S.) , GC Aesthetics (Dublin, Ireland) , POLYTECH Health & Aesthetics GmbH (Dieburg, Germany) , AbbVie Inc. (Illinois, U.S.) , Mentor Worldwide LLC (California, U.S.) , CEREPLAS (Cambrai, France) , Establishment Labs S.A. (Alajuela, Costa Rica) , LABORATOIRES ARION (Sophia Antipolis, France) , Other Players

Sientra, Inc. (NASDAQ:SIEN) Analysts at William Blair dropped their FY2021 earnings per share estimates for Sientra in a report released on Wednesday, November 10th. William Blair analyst M. Kaczor now anticipates that the medical instruments supplier will post earnings per share of ($1.00) for the year, down from their prior estimate of ($0.75). William []

Overview of Global Breast Implants Market: An international Breast Implants Market report proves to be the finest and excellent Market report as it is generated with the myriad of critical factors. To show Marketplace clearly, most up to date Market insights